These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37406559)

  • 21. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
    Taquet M; Dercon Q; Harrison PJ
    Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
    PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of COVID-19 vaccination on epileptic seizures in patients with epilepsy: A clinical observation in China.
    Huang A; Lu Y; Ji J; Yao Y; Guan S; Chen Z; Yu L
    Hum Vaccin Immunother; 2022 Nov; 18(6):2141519. PubMed ID: 36412219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PwE): A cross-sectional study.
    Massoud F; Ahmad SF; Hassan AM; Alexander KJ; Al-Hashel J; Arabi M
    Seizure; 2021 Nov; 92():2-9. PubMed ID: 34391030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Depression and Anxiety Following Self-reported COVID-19-Like Symptoms vs SARS-CoV-2 Seropositivity in France.
    Rouquette A; Descarpentry A; Dione F; Falissard B; Legleye S; Vuillermoz C; Pastorello A; Meyer L; Warszawski J; Davisse-Paturet C; Melchior M;
    JAMA Netw Open; 2023 May; 6(5):e2312892. PubMed ID: 37166797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 outbreak: The impact of stress on seizures in patients with epilepsy.
    Huang S; Wu C; Jia Y; Li G; Zhu Z; Lu K; Yang Y; Wang F; Zhu S
    Epilepsia; 2020 Sep; 61(9):1884-1893. PubMed ID: 32761900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telemedicine in epilepsy management during the coronavirus disease 2019 pandemic.
    Kikuchi K; Hamano SI; Horiguchi A; Nonoyama H; Hirata Y; Matsuura R; Koichihara R; Oka A; Hirano D
    Pediatr Int; 2022 Jan; 64(1):e14972. PubMed ID: 34460985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between COVID-19 and epilepsy during the omicron surge: A cross-sectional survey conducted in China tertiary hospital.
    Li X; Sun S; Yan C; Liu X
    Epilepsy Behav Rep; 2023; 23():100613. PubMed ID: 37501889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.
    Abel KM; Carr MJ; Ashcroft DM; Chalder T; Chew-Graham CA; Hope H; Kapur N; McManus S; Steeg S; Webb RT; Pierce M
    JAMA Netw Open; 2021 Nov; 4(11):e2134803. PubMed ID: 34783824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of COVID-19 on patients with epilepsy.
    Tedrus GMAS; Silva JFCPD; Barros GS
    Arq Neuropsiquiatr; 2021 Apr; 79(4):310-314. PubMed ID: 33681882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the COVID-19 pandemic on persons with epilepsy in Uganda: A descriptive cross-sectional study.
    Gumisiriza N; Kamoen O; Boven A; Dusabimana A; Nono D; Musisi S; Colebunders R
    Epilepsy Behav; 2022 Mar; 128():108536. PubMed ID: 35104731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?].
    Kara E; Tanır F; Demirhindi H; Mete B; Kibar F; Çetiner S; Candevir A; İnaltekin A
    Mikrobiyol Bul; 2022 Jul; 56(3):566-573. PubMed ID: 35960246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of depression, anxiety, and psychological distress in patients with epilepsy during COVID-19: A systematic review.
    Tashakori-Miyanroudi M; Souresrafil A; Hashemi P; Jafar Ehsanzadeh S; Farrahizadeh M; Behroozi Z
    Epilepsy Behav; 2021 Dec; 125():108410. PubMed ID: 34781062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of one-year COVID-19 containment measures in patients with mesial temporal lobe epilepsy: A longitudinal survey-based study.
    Sammarra I; Martino I; Caligiuri ME; Giugno A; Fortunato F; Labate A; Gambardella A
    Epilepsy Behav; 2022 Mar; 128():108600. PubMed ID: 35151188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study.
    Hua Q; Zhang H; Yao P; Xu N; Sun Y; Lu H; Xu F; Liao Y; Yang J; Mao H; Zhang Y; Zhu H; Hu X; Lv H; Jiang J
    Front Immunol; 2022; 13():939311. PubMed ID: 36032136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.
    Hall V; Foulkes S; Insalata F; Kirwan P; Saei A; Atti A; Wellington E; Khawam J; Munro K; Cole M; Tranquillini C; Taylor-Kerr A; Hettiarachchi N; Calbraith D; Sajedi N; Milligan I; Themistocleous Y; Corrigan D; Cromey L; Price L; Stewart S; de Lacy E; Norman C; Linley E; Otter AD; Semper A; Hewson J; D'Arcangelo S; Chand M; Brown CS; Brooks T; Islam J; Charlett A; Hopkins S;
    N Engl J Med; 2022 Mar; 386(13):1207-1220. PubMed ID: 35172051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medium-term changes in patients with epilepsy during the COVID-19 pandemic.
    Gonzalez-Martinez A; Planchuelo-Gómez Á; Vieira Campos A; Martínez-Dubarbie F; Vivancos J; De Toledo-Heras M
    Acta Neurol Scand; 2021 Oct; 144(4):450-459. PubMed ID: 34195984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of COVID-19 on quality of life in people with epilepsy, and a multinational comparison of clinical and psychological impacts.
    Koh MY; Lim KS; Fong SL; Khor SB; Tan CT
    Epilepsy Behav; 2021 Apr; 117():107849. PubMed ID: 33631434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers.
    Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Shibata ARO; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):75-81. PubMed ID: 35351217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.